Stay updated on LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page.

Latest updates to the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe webpage has updated its date references to include February 2025 while removing older dates from January 2025. Additionally, a notice regarding service performance and contact information for assistance has been removed.SummaryDifference2%
- Check36 days agoNo Change Detected
- Check43 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check50 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check57 days agoChange DetectedNew updates have been added regarding a study of LY3484356 for advanced or metastatic breast cancer, along with helpful links from Eli Lilly, while several previous updates from September 2024 have been removed.SummaryDifference1%
- Check65 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check72 days agoChange DetectedThe website has been updated to include a new type of intervention in version 2.14.0, while the previous version 2.13.3 has removed the type of intervention and a study link related to LY3484356 for advanced or metastatic breast cancer.SummaryDifference0.8%
Stay in the know with updates to LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page.